Daniel M Huck1, Haddy Nalubwama2, Chris T Longenecker3, Scott H Frank4, Emmy Okello5, Allison R Webel6. 1. School of Medicine, Case Western Reserve University, Cleveland, OH, USA. 2. School of Public Health, Makerere University, Kampala, Uganda. 3. Division of Cardiovascular Medicine, University Hospitals, Cleveland, OH, USA. 4. Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA. 5. Uganda Heart Institute, Mulago Hospital, Kampala, Uganda. 6. Frances Payne Bolton School of Nursing, Case Western Reserve University, Cleveland, OH, USA. Electronic address: Allison.webel@case.edu.
Abstract
BACKGROUND: Rheumatic heart disease (RHD) is the most common cause of heart disease among Ugandans age 15 to 49 years. Secondary prophylaxis with monthly injection of benzathine penicillin is effective in preventing recurrence of acute rheumatic fever and worsening of RHD, but adherence rates are poor in Uganda. OBJECTIVES: This study sought to identify health behaviors, attitudes, and health care system factors that influence adherence to RHD secondary prophylaxis. METHODS: We conducted 5 structured focus groups with 36 participants on monthly penicillin injections for RHD in Kamplala, Uganda. Transcripts were analyzed using qualitative description analysis and health behavior models. RESULTS: Most participants were female (64%), from an urban area (81%), and had family income less than US$1 daily (69%). Ages ranged from 14 to 58 years. Median prophylaxis duration was 1.42 years and 58% were adherent (≥80% of injections). Key facilitators include perceived worsening of disease with missing injections, personal motivation, a reminder system for injections, supportive family and friends, and a positive relationship with health care providers. Barriers to adherence include lack of resources for transportation and medications, fear of injection pain, poor patient-provider communication, and poor availability of clinics and providers able to give injections. CONCLUSIONS: We identified key facilitators and barriers to secondary prophylaxis for RHD from the patient perspective framed within the socioecological model. Our findings provide direction for intervention development to improve national RHD secondary prophylaxis.
BACKGROUND:Rheumatic heart disease (RHD) is the most common cause of heart disease among Ugandans age 15 to 49 years. Secondary prophylaxis with monthly injection of benzathine penicillin is effective in preventing recurrence of acute rheumatic fever and worsening of RHD, but adherence rates are poor in Uganda. OBJECTIVES: This study sought to identify health behaviors, attitudes, and health care system factors that influence adherence to RHD secondary prophylaxis. METHODS: We conducted 5 structured focus groups with 36 participants on monthly penicillin injections for RHD in Kamplala, Uganda. Transcripts were analyzed using qualitative description analysis and health behavior models. RESULTS: Most participants were female (64%), from an urban area (81%), and had family income less than US$1 daily (69%). Ages ranged from 14 to 58 years. Median prophylaxis duration was 1.42 years and 58% were adherent (≥80% of injections). Key facilitators include perceived worsening of disease with missing injections, personal motivation, a reminder system for injections, supportive family and friends, and a positive relationship with health care providers. Barriers to adherence include lack of resources for transportation and medications, fear of injection pain, poor patient-provider communication, and poor availability of clinics and providers able to give injections. CONCLUSIONS: We identified key facilitators and barriers to secondary prophylaxis for RHD from the patient perspective framed within the socioecological model. Our findings provide direction for intervention development to improve national RHD secondary prophylaxis.
Authors: Rosemary Wyber; Ben J Boyd; Samantha Colquhoun; Bart J Currie; Mark Engel; Joseph Kado; Ganesan Karthikeyan; Mark Sullivan; Anita Saxena; Meru Sheel; Andrew Steer; Joseph Mucumbitsi; Liesl Zühlke; Jonathan Carapetis Journal: Drug Deliv Transl Res Date: 2016-10 Impact factor: 4.617
Authors: Emmy Okello; Chris T Longenecker; Amy Scheel; Twalib Aliku; Joselyn Rwebembera; Grace Mirembe; Craig Sable; Peter Lwabi; Andrea Beaton Journal: Heart Asia Date: 2018-01-13
Authors: Hilary Barker; John G Oetzel; Nina Scott; Michelle Morley; Polly E Atatoa Carr; Keri Bolton Oetzel Journal: Int J Equity Health Date: 2017-11-17
Authors: Christopher T Longenecker; Ankur Kalra; Emmy Okello; Peter Lwabi; John O Omagino; Cissy Kityo; Moses R Kamya; Allison R Webel; Daniel I Simon; Robert A Salata; Marco A Costa Journal: Glob Heart Date: 2018-04-21
Authors: Joselyn Rwebembera; Bruno Ramos Nascimento; Neema W Minja; Sarah de Loizaga; Twalib Aliku; Luiza Pereira Afonso Dos Santos; Bruno Fernandes Galdino; Luiza Silame Corte; Vicente Rezende Silva; Andrew Young Chang; Walderez Ornelas Dutra; Maria Carmo Pereira Nunes; Andrea Zawacki Beaton Journal: Pathogens Date: 2022-01-28